Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Capital Expenditures (2016 - 2022)

Historic Capital Expenditures for Jaguar Health (JAGX) over the last 5 years, with Q3 2022 value amounting to -$1.1 million.

  • Jaguar Health's Capital Expenditures changed N/A to -$1.1 million in Q3 2022 from the same period last year, while for Mar 2023 it was -$1.1 million, marking a year-over-year change of. This contributed to the annual value of $16000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, Jaguar Health's Capital Expenditures is -$1.1 million.
  • In the past 5 years, Jaguar Health's Capital Expenditures ranged from a high of $7000.0 in Q1 2020 and a low of -$1.1 million during Q3 2022
  • For the 4-year period, Jaguar Health's Capital Expenditures averaged around -$271868.2, with its median value being $6263.5 (2018).
  • Examining YoY changes over the last 5 years, Jaguar Health's Capital Expenditures showed a top increase of 1428.57% in 2021 and a maximum decrease of 1428.57% in 2021.
  • Over the past 4 years, Jaguar Health's Capital Expenditures (Quarter) stood at $6527.0 in 2018, then grew by 7.25% to $7000.0 in 2020, then dropped by 14.29% to $6000.0 in 2021, then tumbled by 18550.0% to -$1.1 million in 2022.
  • Its Capital Expenditures stands at -$1.1 million for Q3 2022, versus $6000.0 for Q1 2021 and $7000.0 for Q1 2020.